Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 1
1992 2
1993 2
1994 5
1995 3
1996 4
1997 4
1998 4
1999 2
2000 3
2001 1
2002 5
2003 1
2004 2
2005 5
2006 7
2007 10
2008 11
2009 7
2010 11
2011 21
2012 19
2013 17
2014 10
2015 17
2016 39
2017 37
2018 28
2019 17
2020 45
2021 24
2022 13
2023 22
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
Editorial.
Schaper NC. Schaper NC. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:1. doi: 10.1002/dmrr.2754. Diabetes Metab Res Rev. 2016. PMID: 26813613 No abstract available.
Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update).
Hinchliffe RJ, Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, Katsanos K, Mills JL, Nikol S, Reekers J, Venermo M, Zierler RE, Schaper NC; International Working Group on the Diabetic Foot (IWGDF). Hinchliffe RJ, et al. Among authors: schaper nc. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3276. doi: 10.1002/dmrr.3276. Epub 2020 Jan 20. Diabetes Metab Res Rev. 2020. PMID: 31958217
Lessons from Eurodiale.
Schaper NC. Schaper NC. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:21-6. doi: 10.1002/dmrr.2266. Diabetes Metab Res Rev. 2012. PMID: 22271718 Review.
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
Petrie JR, Chaturvedi N, Ford I, Brouwers MCGJ, Greenlaw N, Tillin T, Hramiak I, Hughes AD, Jenkins AJ, Klein BEK, Klein R, Ooi TC, Rossing P, Stehouwer CDA, Sattar N, Colhoun HM; REMOVAL Study Group. Petrie JR, et al. Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609. doi: 10.1016/S2213-8587(17)30194-8. Epub 2017 Jun 11. Lancet Diabetes Endocrinol. 2017. PMID: 28615149 Free PMC article. Clinical Trial.
The unique multidisciplinarity of diabetes-related foot disease.
van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, Monteiro-Soares M, Senneville E, Schaper NC. van Netten JJ, et al. Among authors: schaper nc. Diabetes Metab Res Rev. 2024 May;40(4):e3804. doi: 10.1002/dmrr.3804. Diabetes Metab Res Rev. 2024. PMID: 38616492
350 results